Next-Generation GLP-1 Drugs Show Even Greater Weight Loss
An updated review of nearly 26,000 adults shows emerging multiagonist medications can reduce body weight by nearly a quarter.
Read AnalysisWhat Science Actually Says About Effective Dieting Strategies
The International Society of Sports Nutrition's definitive guidance reveals why protein intake and resistance training beat restrictive diet trends.
Read AnalysisHow Semaglutide Alters Muscle Quality and Everyday Physical Function
A new study reveals semaglutide reduces muscle fat infiltration while preserving everyday physical strength.
Read AnalysisAdding Tirzepatide to Arthritis Therapy Delivers Superior Relief
Combining tirzepatide with standard biologic treatment dramatically improves joint pain, skin symptoms, and physical function in psoriatic arthritis.
Read AnalysisStopping Ozempic or Mounjaro? Study Projects Rapid Weight Regain
New research reveals how quickly patients regain weight after stopping popular GLP-1 medications like Wegovy and Zepbound.
Read AnalysisHow Semaglutide Cuts Calories Even When Hunger Returns
A new 60-week study reveals that semaglutide helps people eat less long-term, even after its subjective appetite-suppressing effects begin to fade.
Read AnalysisOral Semaglutide Slashes Liver Fat and Body Weight
A new clinical trial shows oral semaglutide significantly reduces body fat and improves liver health in people without diabetes.
Read AnalysisPopular GLP-1 Medications Linked to Higher Hair Loss Risk
A new study reveals a significant link between popular GLP-1 receptor agonists and an increased risk of temporary hair shedding.
Read AnalysisOral Semaglutide Shows Promise in Reducing Heavy Drinking
A new clinical trial suggests the blockbuster drug semaglutide could help people struggling with alcohol use disorder cut back on heavy drinking.
Read Analysis